Creatine Kinase MB (CK-MB)
CK-MB is a cardiac biomarker that measures the level of creatine kinase myocardial band in the blood, primarily used to detect damage to heart muscle cells.
CK-MB helps diagnose heart muscle damage, particularly in acute myocardial infarction.
Key facts at a glance
- Units
- ng/mL
- Clinical utility
- diagnostic
- Result kind
- quantitative
- FDA-cleared
- Roche CK-MB, Abbott CK-MB, Siemens CK-MB
Creatine Kinase MB (CK-MB) is an enzyme found predominantly in heart muscle cells. When there is damage to these cells, such as in a heart attack, CK-MB is released into the bloodstream.
The CK-MB test is a diagnostic tool used to measure the levels of this enzyme in the blood. Elevated levels can indicate myocardial infarction or other forms of heart muscle damage.
While CK-MB was once the primary biomarker for diagnosing heart attacks, it has largely been supplanted by troponin tests, which are more specific and sensitive. However, CK-MB is still useful in certain clinical scenarios.
Frequently asked questions
What is the normal range for CK-MB?
How quickly does CK-MB rise after a heart attack?
Sources
- 1
- 2Mayo ClinicSource
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy